retatrutide weight loss results Eli Lilly just announced striking Phase 3 for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide is a triple hormone

During perimenopause, fluctuating oestrogen and progesterone levels can make it harder to regulate appetite, mood, and sleep

GLP-1 RAs have also been associated with pancreatitis, which has predominantly been linked to gallbladder disease as a secondary effect of weight loss [88]

Spacing your thyroid medication 3060 minutes before semaglutide injection and taking it on an empty stomach reduces this risk

For treats, prepare moringa muffins with honey and coconut

Changes in weight often impact blood sugar control, joint comfort, and heart stress

If you experience persistent tiredness that does not improve after a few weeks, seek medical advice from your healthcare team